Detection of copy number changes in genes associated with Parkinson's disease in Iranian patients

Neuroscience Letters

Volumn 551, Issue , 2013, Pages 75-78

  Darvish, Hossein ^a   Movafagh, Abolfazl ^a   Omrani, Mir Davood ^a   Firouzabadi, Saghar Ghasemi ^b   Azargashb, Eznollah ^a   Jamshidi, Javad ^c   Khaligh, Ali ^d   Haghnejad, Leyla ^a   Naeini, Nilofar Safavi ^a   Talebi, Atefeh ^a   Heidari Rostami, Hamid Reza ^a   Noorollahi Moghaddam, Hamid ^e   Karkheiran, Siamak ^f   Shahidi, Gholam Ali ^f   Paknejad, Seyed Mohammad Hassan ^g   Ashrafian, Hossein ^h   Abdi, Siamak ^e   Kayyal, Matin ⁱ   Akbari, Mojdeh ^a   Pedram, Negar ^j   Emamalizadeh, Babak ^a   more..

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

^c FASA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SABZEVAR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g Shefa Neuroscience Center   (Iran)

^h Faculty of Medicine   (Iran)

ⁱ ISLAMIC AZAD UNIVERSITY   (Iran)

^j TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

more..

Author keywords

Copy number changes; Exon dosage; MLPA; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; ATPASE TYPE 13A2; GENOMIC DNA; LEUCINE RICH REPEAT KINASE 2; PARKIN; PHOSPHOTRANSFERASE; PTEN INDUCED PUTATIVE KINASE 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CHILD; CLINICAL ARTICLE; COPY NUMBER VARIATION; DNA EXTRACTION; EXON; FAMILY HISTORY; GENE DOSAGE; GENE MUTATION; GENE REARRANGEMENT; GENETIC ANALYSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IRAN; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; ONSET AGE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD;

COPY NUMBER CHANGES; EXON DOSAGE; MLPA; PARKINSON'S DISEASE;

FEMALE; GENE DOSAGE; HUMANS; IRAN; MALE; PARKINSON DISEASE;

EID: 84882287924     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.07.013     Document Type: Article

References (12)

1. Lesage S., Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum. Mol. Genet. 2009, 18:48-59.
2. Alves G., Forsaa E.B., Pedersen K.F., Dreetz Gjerstad M., Larsen J.P. Epidemiology of Parkinson's disease. J. Neurol. 2008, 255:18-32.
3. Hedrich K., Kann M., Lanthaler A.J., Dalski A., Eskelson C., Landt O., Schwinger E., Vieregge P., Lang A.E., Breakefield X.O., Ozelius L.J., Pramstaller P.P., Klein C. The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum. Mol. Genet. 2001, 10:1649-1656.
4. Gibb W.R., Lees A.J. A comparison of clinical and pathological features of young- and old-onset Parkinson's disease. Neurology 1988, 38:1402-1406.
5. Keyser R.J., Lombard D., Veikondis R., Carr J., Bardien S. Analysis of exon dosage using MLPA in South African Parkinson's disease patients. Neurogenetics 2010, 11:305-312.
6. Chartier-Harlin M.C., Kachergus J., Roumier C., Mouroux V., Douay X., Lincoln S., Levecque C., Larvor L., Andrieux J., Hulihan M., Waucquier N., Defebvre L., Amouyel P., Farrer M., Destée A. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004, 364:1167-1169.
7. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., Winn-Hardy K.G. Alpha-synuclein locus triplication causes Parkinson's disease. Science 2003, 302:841.
8. Abeliovich A., Schmitz Y., Fariñas I., Choi-Lundberg D., Ho W.H., Castillo P.E., Shinsky N., Verdugo J.M., Armanini M., Ryan A., Hynes M., Phillips H., Sulzer D., Rosenthal A. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 2000, 25:239-252.
9. Bonifati V., Rohé C.F., Breedveld G.J., Fabrizio E., De Mari M., Tassorelli C., Tavella A., Marconi R., Nicholl D.J., Chien H.F., Fincati E., Abbruzzese G., Marini P., De Gaetano A., Horstink M.W., Maat-Kievit J.A., Sampaio C., Antonini A., Stocchi F., Montagna P., Toni V., Guidi M., Dalla Libera A., Tinazzi M., De Pandis F., Fabbrini G., Goldwurm S., de Klein A., Barbosa E., Lopiano L., Martignoni E., Lamberti P., Vanacore N., Meco G., Oostra B.A. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 2005, 65:87-95.
10. Hampshire D.J., Roberts E., Crow Y., Bond J., Mubaidin A., Wriekat A.L., Al-Din A., Woods C.G. Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36. J. Med. Genet. 2001, 38:680-682.
11. Kruer M.C., Paudel R., Wagoner W., Sanford L., Kara E., Gregory A., Foltynie T., Lees A., Bhatia K., Hardy J., Hayflick S.J., Houlden H. Analysis of ATP13A2 in large neurodegeneration with brain iron accumulation (NBIA) and dystonia-parkinsonism cohorts. Neurosci. Lett. 2012, 523:35-38.
12. Crosiers D., Ceulemans B., Meeus B., Nuytemans K., Pals P., Van Broeckhoven C., Cras P., Theuns J. Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation. Parkinsonism Relat. Disord. 2011, 17:135-138.